↓ Skip to main content

Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts

Overview of attention for article published in Journal of General Internal Medicine, September 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
11 news outlets
policy
1 policy source
twitter
25 X users
facebook
2 Facebook pages

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
184 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts
Published in
Journal of General Internal Medicine, September 2017
DOI 10.1007/s11606-017-4150-7
Pubmed ID
Authors

Russell P. Bowler, Nadia N Hansel, Sean Jacobson, R. Graham Barr, Barry J. Make, MeiLan K. Han, Wanda K O’Neal, Elizabeth C Oelsner, Richard Casaburi, Igor Barjaktarevic, Chris Cooper, Marilyn Foreman, Robert A. Wise, Dawn L. DeMeo, Edwin K. Silverman, William Bailey, Kathleen F. Harrington, Prescott G. Woodruff, M. Bradley Drummond, for COPDGene and SPIROMICS Investigators

Abstract

Electronic cigarettes (e-cigarettes) are battery-operated nicotine-delivery devices used by some smokers as a cessation tool as well as by never smokers. To determine the usage of e-cigarettes in older adults at risk for or with chronic obstructive pulmonary disease (COPD). Prospective cohorts. COPDGene (N = 3536) and SPIROMICS (N = 1060) subjects who were current or former smokers aged 45-80. Participants were surveyed to determine whether e-cigarette use was associated with longitudinal changes in COPD progression or smoking habits. From 2010 to 2016, participants who had ever used e-cigarettes steadily increased to 12-16%, but from 2014 to 2016 current use was stable at ~5%. E-cigarette use in African-Americans (AA) and whites was similar; however, AA were 1.8-2.9 times as likely to use menthol-flavored e-cigarettes. Current e-cigarette and conventional cigarette users had higher nicotine dependence and consumed more nicotine than those who smoked only conventional cigarettes. E-cigarette users had a heavier conventional cigarette smoking history and worse respiratory health, were less likely to reduce or quit conventional cigarette smoking, had higher nicotine dependence, and were more likely to report chronic bronchitis and exacerbations. Ever e-cigarette users had more rapid decline in lung function, but this trend did not persist after adjustment for persistent conventional cigarette smoking. E-cigarette use, which is common in adults with or at risk for COPD, was associated with worse pulmonary-related health outcomes, but not with cessation of smoking conventional cigarettes. Although this was an observational study, we find no evidence supporting the use of e-cigarettes as a harm reduction strategy among current smokers with or at risk for COPD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 184 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 184 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 13%
Student > Bachelor 23 13%
Researcher 21 11%
Professor 14 8%
Student > Ph. D. Student 11 6%
Other 29 16%
Unknown 63 34%
Readers by discipline Count As %
Medicine and Dentistry 37 20%
Nursing and Health Professions 21 11%
Psychology 10 5%
Biochemistry, Genetics and Molecular Biology 9 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 25 14%
Unknown 74 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 105. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2024.
All research outputs
#402,452
of 25,507,011 outputs
Outputs from Journal of General Internal Medicine
#319
of 8,209 outputs
Outputs of similar age
#8,492
of 323,514 outputs
Outputs of similar age from Journal of General Internal Medicine
#5
of 68 outputs
Altmetric has tracked 25,507,011 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,209 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,514 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.